Skip to content

Decitabine Hydroxy Impurity Related Compound 2

Decitabine Hydroxy Impurity Related Compound 2

Product Description
CAT No.
ALN-D019052
CAS No.
NA
Mol. F.
C8H14N4O5
Mol. Wt.
246.2
Stock
Please Inquire
RFQ
Chemical Name : N-((Z)-N’-(((2S,4S,5R)-4,5-Dihydroxytetrahydro-2H-pyran-2-yl)carbamoyl)carbamimidoyl)formamide
Smiles : O[C@H]1[C@@H](O)C[C@@H](NC(/N=C(N)\NC([H])=O)=O)OC1
Inchi : InChI=1/C46H63NO7/c1-3-4-18-28-45(2,51)29-27-41-40(42(48)30-43(41)49)25-16-5-6-17-26-44(50)47-46(34-52-31-37-19-10-7-11-20-37,35-53-32-38-21-12-8-13-22-38)36-54-33-39-23-14-9-15-24-39/h5,7-16,19-24,27,29,40-43,48-49,51H,3-4,6,17-18,25-26,28,30-36H2,1-2H3,(H,47,50)/b16-5+,29-27+

Development, validation, and clinical application of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantifica0074ion of total intracellular -decitabine nucleotides and genomic DNA incorporated -decitabine and 5-methyl-2 -deoxycytidine

Jeroen Roosendaal , Hilde Rosinga, Luc Lucas a, Aram Oganesianc, Jan H.M. Schellens b,d,e, Jos H. BeijnennJournal of Pharmaceutical and Biomedical Analysis 164 (2019) 16u201326

Isolation, characterization, and properties of a labile hydrolysis product of the antitumor nucleoside, 5-azacytidine

John A. Beisler – J. Med. Chem. 1978, 21, 2, 204–208

Stability indicating RP-HPLC Method Devlopment and Validation of Decitabine Drug in Formulation

Glory hepsiba1

Request For Quotation

Related Products